- Home
- ALMS vs CGC Comparison
ALMS vs CGC Comparison
Compare ALMS & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALMS
- CGC
- Stock Information
- Founded
- ALMS 2021
- CGC 2009
- Country
- ALMS United States
- CGC Canada
- Employees
- ALMS N/A
- CGC N/A
- Industry
- ALMS
- CGC Pharmaceuticals and Biotechnology
- Sector
- ALMS
- CGC Health Care
- Exchange
- ALMS NYSE
- CGC Nasdaq
- Market Cap
- ALMS 469.0M
- CGC 379.3M
- IPO Year
- ALMS 2024
- CGC N/A
- Fundamental
- Price
- ALMS $7.41
- CGC $2.23
- Analyst Decision
- ALMS Strong Buy
- CGC Sell
- Analyst Count
- ALMS 6
- CGC 1
- Target Price
- ALMS $29.60
- CGC $2.00
- AVG Volume (30 Days)
- ALMS 121.0K
- CGC 5.9M
- Earning Date
- ALMS 02-15-2025
- CGC 02-07-2025
- Dividend Yield
- ALMS N/A
- CGC N/A
- EPS Growth
- ALMS N/A
- CGC N/A
- EPS
- ALMS N/A
- CGC N/A
- Revenue
- ALMS N/A
- CGC $207,628,706.00
- Revenue This Year
- ALMS N/A
- CGC N/A
- Revenue Next Year
- ALMS N/A
- CGC $2.35
- P/E Ratio
- ALMS N/A
- CGC N/A
- Revenue Growth
- ALMS N/A
- CGC N/A
- 52 Week Low
- ALMS $6.75
- CGC $2.15
- 52 Week High
- ALMS $13.53
- CGC $14.92
- Technical
- Relative Strength Index (RSI)
- ALMS N/A
- CGC 26.31
- Support Level
- ALMS N/A
- CGC $2.15
- Resistance Level
- ALMS N/A
- CGC $2.29
- Average True Range (ATR)
- ALMS 0.00
- CGC 0.15
- MACD
- ALMS 0.00
- CGC -0.02
- Stochastic Oscillator
- ALMS 0.00
- CGC 8.70
About ALMS ALUMIS INC
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.
About CGC Canopy Growth Corporation
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.